NGM Biopharmaceuticals, Inc.
NASDAQ:NGM
1.54 (USD) • At close April 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q2 | 2017 Q4 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||||||||||||
Current Assets: | |||||||||||||||||||||||
Cash & Cash Equivalents
| 58.815 | 51.476 | 53.271 | 67.549 | 73.456 | 101.449 | 63.379 | 109.872 | 151.795 | 145.826 | 99.403 | 148.113 | 147.017 | 253.976 | 249.317 | 256.952 | 245.598 | 303.016 | 265.072 | 47.313 | 56.923 | 38.912 | 25.593 |
Short Term Investments
| 88.369 | 114.569 | 140.273 | 163.455 | 198.036 | 198.701 | 234.429 | 219.96 | 214.458 | 237.603 | 291.147 | 264.543 | 148.139 | 33.973 | 62.778 | 71.517 | 98.913 | 53.557 | 97.116 | 146.126 | 149.71 | 150.315 | 148.092 |
Cash and Short Term Investments
| 147.184 | 166.045 | 193.544 | 231.004 | 271.492 | 300.15 | 297.808 | 329.832 | 366.253 | 383.429 | 390.55 | 412.656 | 295.156 | 287.949 | 312.095 | 328.469 | 344.511 | 356.573 | 362.188 | 193.439 | 206.633 | 189.227 | 173.685 |
Net Receivables
| 0.058 | 0 | 0.736 | 1.257 | 7.58 | 4.38 | 6.674 | 0.103 | 4.945 | 4.4 | 3.586 | 4.925 | 6.433 | 7.215 | 3.079 | 0.742 | 5.206 | 0 | 0.881 | 0 | 3.669 | 0 | 0 |
Inventory
| 0 | 0 | 1.499 | 1.499 | 0 | 0 | 0 | 0 | -4.945 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 9.202 | 7.994 | 8.623 | 8.769 | 9.787 | 11.17 | 14.357 | 7.687 | 13.027 | 8.054 | 8.993 | 8.268 | 6.837 | 7.076 | 7.448 | 9.096 | 5.531 | 7.747 | 5.275 | 5.706 | 4.255 | 2.249 | 1.848 |
Total Current Assets
| 156.444 | 177.038 | 204.402 | 242.529 | 288.859 | 315.7 | 318.839 | 337.622 | 379.28 | 395.883 | 403.129 | 425.849 | 308.426 | 302.24 | 322.622 | 338.307 | 355.248 | 364.32 | 368.344 | 199.145 | 214.557 | 191.476 | 175.533 |
Non-Current Assets: | |||||||||||||||||||||||
Property, Plant & Equipment, Net
| 7.033 | 7.819 | 8.827 | 9.552 | 10.592 | 10.916 | 11.567 | 13.006 | 14.116 | 11.452 | 12.79 | 13.733 | 14.526 | 15.773 | 17.321 | 18.274 | 19.475 | 20.485 | 22.172 | 23.319 | 23.893 | 26.731 | 24.873 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 2.455 | 2.455 | 2.455 | 2.455 | 3.954 | 3.954 | 1.499 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.944 | 45.15 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 2.936 | 4.838 | 4.86 | 4.301 | 3.997 | 5.296 | 5.466 | 9.145 | 8.991 | 8.523 | 7.092 | 5.959 | 6.091 | 8.069 | 7.341 | 4.12 | 5.68 | 5.81 | 6.187 | 9.163 | 7.635 | 3.412 | 3.385 |
Total Non-Current Assets
| 12.424 | 15.112 | 16.142 | 16.308 | 18.543 | 20.166 | 18.532 | 22.151 | 23.107 | 19.975 | 19.882 | 19.692 | 20.617 | 23.842 | 24.662 | 22.394 | 25.155 | 26.295 | 28.359 | 32.482 | 31.528 | 46.087 | 73.408 |
Total Assets
| 168.868 | 192.15 | 220.544 | 258.837 | 307.402 | 335.866 | 337.371 | 359.773 | 402.387 | 415.858 | 423.011 | 445.541 | 329.043 | 326.082 | 347.284 | 360.701 | 380.403 | 390.615 | 396.703 | 231.627 | 246.085 | 237.563 | 248.941 |
Liabilities & Equity: | |||||||||||||||||||||||
Current Liabilities: | |||||||||||||||||||||||
Account Payables
| 2.982 | 4.69 | 5.855 | 13.293 | 8.453 | 3.565 | 6.873 | 4.815 | 5.246 | 7.632 | 5.141 | 7.535 | 9.663 | 1.613 | 1.934 | 3.648 | 9.026 | 4.457 | 3.164 | 4.203 | 5.775 | 4.196 | 1.892 |
Short Term Debt
| 0 | 1.381 | 2.751 | 4.073 | 5.385 | 5.307 | 5.229 | 5.153 | 5.077 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0.107 | 0.689 | 0.376 | 0.366 | 6.967 | 6.497 | 5.117 | 17.774 | 12.288 | 4.963 | 0 | 0 | 4.586 | 2.074 | 0 | 4.872 | 14.624 | 17.441 | 22.041 | 19.025 | 20.819 | 21.358 |
Other Current Liabilities
| 17.099 | 16.167 | 19.128 | 20.161 | 33.638 | 32.757 | 23.94 | 29.478 | 33.258 | 37.808 | 34.939 | 32.774 | 32.92 | 31.517 | 29.694 | 24.814 | 25.82 | 21.397 | 18.048 | 16.635 | 16.686 | 13.885 | 13.643 |
Total Current Liabilities
| 20.081 | 22.345 | 28.423 | 37.903 | 47.842 | 48.596 | 42.539 | 44.563 | 61.355 | 57.728 | 45.043 | 40.309 | 42.583 | 37.716 | 33.702 | 28.462 | 39.718 | 40.478 | 38.653 | 42.879 | 41.486 | 38.9 | 36.893 |
Non-Current Liabilities: | |||||||||||||||||||||||
Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 1.381 | 2.751 | 4.073 | 5.385 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.942 | 13.342 | 22.742 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0.149 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.091 | 4.893 | 5.655 | 6.417 | 11.663 | 12.418 | 13.267 | 9.966 | 10.951 | 11.92 | 307.926 | 13.78 | 308.77 | 310.284 |
Total Non-Current Liabilities
| 0.149 | 0 | 0 | 17.366 | 14.204 | 1.381 | 2.751 | 4.073 | 5.385 | 4.091 | 4.893 | 5.655 | 6.417 | 11.663 | 12.418 | 13.267 | 9.966 | 10.951 | 11.92 | 307.926 | 17.722 | 322.112 | 333.026 |
Total Liabilities
| 20.23 | 22.345 | 28.423 | 37.903 | 47.842 | 49.977 | 45.29 | 48.636 | 66.74 | 61.819 | 49.936 | 45.964 | 49 | 49.379 | 46.12 | 41.729 | 49.684 | 51.429 | 50.573 | 350.805 | 59.208 | 361.012 | 369.919 |
Equity: | |||||||||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 418.888 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 380.403 | 390.615 | 396.703 | 295.072 | 0 | 0.498 | 0 |
Common Stock
| 0.083 | 0.083 | 0.083 | 0.082 | 0.082 | 0.082 | 0.079 | 0.078 | 0.078 | 0.078 | 0.077 | 0.077 | 0.071 | 0.069 | 0.069 | 0.068 | 0.067 | 0.066 | 0.066 | 0.007 | 0.054 | 0.013 | 0.012 |
Retained Earnings
| -724.008 | -696.338 | -667.541 | -629.28 | -581.633 | -545.196 | -497.935 | -451.416 | -418.966 | -391.732 | -362.867 | -326.175 | -298.631 | -270.64 | -240.875 | -215.259 | -196.144 | -180.203 | -169.286 | -161.617 | -147.193 | -153.841 | -146.7 |
Accumulated Other Comprehensive Income/Loss
| 0.018 | -0.078 | -0.149 | -0.097 | -0.302 | -0.915 | -1.077 | -0.677 | -0.129 | -0.011 | 0.005 | -0.018 | 0.004 | 0.015 | 0.137 | -0.055 | 0.025 | 0.099 | 0.102 | -0.045 | -0.267 | -0.498 | -0.431 |
Other Total Stockholders Equity
| 872.545 | 866.138 | 859.728 | 850.229 | 841.413 | 831.918 | 791.014 | 763.152 | 335.776 | 745.704 | 735.86 | 725.693 | 578.599 | 547.259 | 541.833 | 534.218 | 146.368 | 128.609 | 118.545 | -252.595 | 39.21 | 30.379 | 26.141 |
Total Shareholders Equity
| 148.638 | 169.805 | 192.121 | 220.934 | 259.56 | 285.889 | 292.081 | 311.137 | 335.647 | 354.039 | 373.075 | 399.577 | 280.043 | 276.703 | 301.164 | 318.972 | 330.719 | 339.186 | 346.13 | -119.178 | 186.877 | -123.449 | -120.978 |
Total Equity
| 148.638 | 169.805 | 192.121 | 220.934 | 259.56 | 285.889 | 292.081 | 311.137 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities & Shareholders Equity
| 168.868 | 192.15 | 220.544 | 258.837 | 307.402 | 335.866 | 337.371 | 359.773 | 402.387 | 415.858 | 423.011 | 445.541 | 329.043 | 326.082 | 347.284 | 360.701 | 380.403 | 390.615 | 396.703 | 231.627 | 246.085 | 237.563 | 248.941 |